Vera Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.284; its P/E ratio is -17.29; Vera Therapeutics is scheduled to report earnings on June 20, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 482.00K	$ 482.00K	$ 482.00K	$ 482.00K	$ 482.00K
Gross Profit	$ 482.00K	$ 482.00K	$ 482.00K	$ 482.00K	$ 482.00K
EBIT	$ -24.75M	$ -19.09M	$ -19.39M	$ -28.98M	$ -32.45M
EBITDA	$ -24.22M	-	$ -18.82M	$ -28.40M	$ -31.86M
Net Income Common Stockholders	$ -25.80M	$ -20.04M	$ -20.16M	$ -29.85M	$ -32.38M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 160.72M	$ 159.94M	$ 181.02M	$ 197.15M	$ 114.65M
Total Assets	$ 175.55M	$ 175.62M	$ 195.18M	$ 209.56M	$ 131.44M
Total Debt	$ 53.71M	$ 29.52M	$ 30.09M	$ 30.68M	$ 31.29M
Net Debt	$ -107.01M	$ -130.42M	$ -150.93M	$ -166.47M	$ -83.37M
Total Liabilities	$ 73.86M	$ 51.91M	$ 54.66M	$ 51.90M	$ 54.53M
Stockholders Equity	$ 101.69M	$ 123.71M	$ 140.52M	$ 157.71M	$ 76.91M
Cash Flow	-
Free Cash Flow	$ -25.21M	-	$ -17.77M	$ -26.29M	$ -21.16M
Operating Cash Flow	$ -25.14M	$ -22.97M	$ -17.77M	$ -26.29M	$ -21.16M
Investing Cash Flow	$ 18.56M	$ 16.23M	$ -86.45M	$ 12.23M	$ 13.44M
Financing Cash Flow	$ 24.83M	$ 297.00K	$ 432.00K	$ 107.98M	$ 20.71M

Currency in USD

Vera Therapeutics Earnings and Revenue History

Income Statement >

Vera Therapeutics Debt to Assets

Balance Sheet >

Vera Therapeutics Cash Flow

Cash Flow >

Vera Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing